Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Notes underwriting agrmnt
Inv. presentation
Quarterly results
Acq. announced
|
|
Vistagen Therapeutics, Inc. (VTGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 9.9% stake in Vistagen Therapeutics, Inc. |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 0% stake in VistaGen Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 0% stake in VistaGen Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 0% stake in VistaGen Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| ACUTA CAPITAL PARTNERS, LLC reports a 0% stake in VistaGen Therapeutics, Inc. |
| 02/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/08/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in VistaGen Therapeutics, Inc. |
| 02/15/2022 |
SC 13G/A
| ACUTA CAPITAL PARTNERS, LLC reports a 5.9% stake in VistaGen Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 8% stake in VistaGen Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/22/2021 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 4.8% stake in VistaGen Therapeutics, Inc. |
| 02/11/2020 |
SC 13G/A
| SPHERA FUNDS MANAGEMENT LTD. reports a 2.7% stake in VistaGen Therapeutics, Inc. |
| 02/13/2019 |
SC 13G/A
| SPHERA FUNDS MANAGEMENT LTD. reports a 9% stake in VistaGen Therapeutics, Inc. |
| 02/08/2019 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 4.4% stake in VistaGen Therapeutics, Inc. |
| 01/03/2019 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in VistaGen Therapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 9.5% stake in VistaGen Therapeutics, Inc. |
| 02/09/2018 |
SC 13G/A
| CVI Investments, Inc. reports a 4.9% stake in VistaGen Therapeutics, Inc. |
| 01/12/2018 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in VistaGen Therapeutics, Inc. |
| 01/09/2018 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 9.7% stake in VistaGen Therapeutics, Inc. |
| 01/27/2017 |
SC 13G/A
| Empery Asset Management, LP reports a 8.6% stake in VistaGen Therapeutics, Inc. |
| 01/24/2017 |
SC 13G/A
| SPHERA FUNDS MANAGEMENT LTD. reports a 10.5% stake in VistaGen Therapeutics, Inc. |
| 01/10/2017 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in VistaGen Therapeutics, Inc. |
| 07/01/2016 |
SC 13G/A
| Calm Seas Capital LLC reports a 2.1% stake in VISTAGEN THERAPEUTICS, INC. |
| 05/24/2016 |
SC 13G/A
| NEXTHERA CAPITAL LP reports a 1.8% stake in VistaGen Therapeutics, Inc. |
| 02/18/2015 |
SC 13G/A
| Platinum Long Term Growth VII, LLC reports a 10% stake in VistaGen Therapeutics, Inc. |
| 02/17/2015 |
SC 13G/A
| Platinum Long Term Growth VII, LLC reports a 10% stake in VistaGen Therapeutics, Inc. |
| 02/14/2014 |
SC 13G/A
| Platinum Long Term Growth VII, LLC reports a 9.9% stake in VistaGen Therapeutics, Inc. |
| 02/15/2013 |
SC 13G/A
| Platinum Long Term Growth VII, LLC reports a 9.9% stake in VistaGen Therapeutics, Inc. |
| 01/12/2012 |
SC 13G/A
| Platinum Long Term Growth VII, LLC reports a 9.9% stake in VistaGen Therapeutics, Inc. |
|
|